Author details

Full Name

Rajan Jain

Affiliation

ORCID

Career Start Year

1999

Papers

155

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37381160	Neuroimaging findings in 4342 hospitalized COVID-19 subjects: A multicenter report from the United States and Europe.	J Neuroimaging	2023
35953567	MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma.	Neuroradiology	2023
35876874	Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification.	Neuroradiology	2023
35917833	Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.	Neuro Oncol	2023
36404047	Acute Neurological Complications of Coronavirus Disease.	Neuroimaging Clinics of North America	2023
37760146	MRI-Based Deep Learning Method for Classification of IDH Mutation Status.		2023
37584601	Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.	Cancer Discov	2023
36702828	Author Correction: Federated learning enables big data for rare cancer boundary detection.	Nat Commun	2023
37440372	Occipital Nocardia Abscess Presenting With Positive Visual Phenomenon and Quadrantanopsia.	J Neuroophthalmol	2023
35890885	A Pipeline for the Implementation and Visualization of Explainable Machine Learning for Medical Imaging Using Radiomics Features.	Sensors	2022
32839867	Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System.	Neurocrit Care	2021
33630091	Radiogenomics identifying important biological pathways in gliomas.	Neuro-Oncology	2021
33528739	Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients.	Journal of Neuro-Oncology	2021
33674942	Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19.	Neurocrit Care	2021
34105198	COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.	J Neuroimaging	2021
33661425	Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.	J Neurooncol	2021
32706862	Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.	Neuro Oncol	2021
33190362	Performance Comparison of Compressed Sensing Algorithms for Accelerating T Mapping of Human Brain.	Journal of Magnetic Resonance Imaging	2021
32968850	Risk factors for intracerebral hemorrhage in patients with COVID-19.	J Thromb Thrombolysis	2021
32554424	Cerebral Venous Thrombosis Associated with COVID-19.	AJNR Am J Neuroradiol	2020
32327434	Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.	AJNR Am J Neuroradiol	2020
32064507	Real world use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.	Neuro-Oncology	2020
32357326	Letter to the Editor. The T2-FLAIR-mismatch sign.	Neurosurgical Focus	2020
32060714	MR image phenotypes may add prognostic value to clinical features in IDH wild-type lower-grade gliomas.	European Radiology	2020
32162004	Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.	European Radiology	2020
31714193	MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.	Radiology	2020
32152622	AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.	Neuro Oncol	2020
31655242	Possible Empirical Evidence of Glymphatic System on Computed Tomography After Endovascular Perforations.	World Neurosurgery	2020
32467189	Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.		2020
32447193	COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.	J Neurol Sci	2020
32271284	Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.	Topics in Magnetic Resonance Imaging	2020
32759189	Herpes zoster lumbar radiculitis.	Neurology	2020
32755456	Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19.	Stroke	2020
32642706	Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes.	Neurooncol Adv	2020
32527845	Evolving Neuroimaging Findings during COVID-19.		2020
32689588	Hemorrhagic stroke and anticoagulation in COVID-19.	J Stroke Cerebrovasc Dis	2020
32740813	Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.	European Radiology	2020
32909947	Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy.	Elife	2020
32909115	Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign.	J Neurooncol	2020
33106782	COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms.	SN Compr Clin Med	2020
31248860	Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.	AJNR Am J Neuroradiol	2019
30397180	Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.	Clin Cancer Res	2019
30332296	State of the Art: Machine Learning Applications in Glioma Imaging.	American Journal of Roentgenology	2019
30565056	There is an exception to every rule-T2-FLAIR mismatch sign in gliomas.	Neuroradiology	2019
30646519	Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma.	Cancers (Basel)	2019
30705071	Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in <i>IDH</i>-Mutant Lower Grade Gliomas.	AJNR Am J Neuroradiol	2019
31134296	MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.	Neuroradiology	2019
29405952	State of the Art Treatment and Surveillance Imaging of Glioblastomas.	Seminars in Roentgenology	2018
28973554	Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.	Neurosurgery	2018
29959694	Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study.	J Neurooncol	2018